The Uncorrected Proofs
IMPORTANT TO KNOW
After the authors have received the letter of acceptance and have paid the publication fee, the uncorrected version of their article appears instantly on our web site. It provides DOI and dates of acceptance and online posting.
This „early bird“ version of the article has been made available at this early stage in order to provide the fastest access to the article and is not intended to be the final version. The manuscript will undergo copyediting, typesetting and review of the resulting proof before it is published in its final form. To be noted that changes to the article should not be requested at this stage; for the proofreading the authors will be contacted by the Editor. This first version of the article will be replaced by the final version as soon as the latter becomes available and moved from „Uncorrected proofs“ to the „Papers in press“.
X. Zhang, Y. Zhang, Z. Cao, Z. Zhao, H. Zhao and X. Yang
Naturally occurring bergapten exhibits potent anticancer effects in cisplatin-resistant breast cancer cells: Role of PI3K/AKT signaling pathway
A. Kohutova, D. Münzova, M. Pešl and V. Rotrekl
α1-Adrenoceptor agonist methoxamine inhibits base excision repair via inhibition of apurinic/apyrimidinic endonuclease 1 (APE1)
C. Xing, Y. Zhang, R. Su and R. Wu
Post-transcriptional suppression of SP1 by miR-375 regulates the growth and epithelial to mesenchymal transition of human osteosarcoma cells
M. Dobravc Verbič, M. Brvar and M. Kerec Kos
Adverse drug reactions in the ambulatory internal patients at the emergency department: Focus on causality assessment and drug-drug interaction
S. Fan, H. Wang, D. Wu and L. Liu
Pharmaceutical approaches for COVID-19: An update on current therapeutic opportunities
J. M. Serrano, M. Escorial García, C. M. Ferri, J. B. Bernabeu, C. C. Tapia, D. M. González and Ana M. Peiró Peiró
Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences
R. Liu, C. Jiang, Z. Zhao, Y. Lv and G. Wang
Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro